gvtcx

Provision of a Systemic Anti-Cancer Therapy (SACT) Compounding and Nursing Service

key details

Value£8,000,000
Statuscomplete
Category (CPV) 79624000 +1 more
RegionWales
Deadline22 Jan 2024
Procedureopen
OCIDocds-h6vhtk-04264f

Award

SupplierValueDateStatus
LloydsPharmacy · · active

description

The NHS Wales Shared Services Partnership (hosted by Velindre NHS Trust) are acting on behalf of Velindre NHS Trust who sought to award a contract for a Parenteral Systemic Anti-cancer Therapy (SACT) service. This service is to be provided on behalf of Velindre Cancer Centre which is part of Velindre University NHS Trust.

In recent years there has been a surge of new SACT approved by NICE / AWMSG, including immunotherapy to treat solid tumour cancers. This surge is associated with significant increased demand and associated pressure on resources, which will continue to grow as more drugs / indications are NICE approved. This requirement is to increase capacity in order to help meet SACT demand as required. The Medicines@Home Service, as part of the Pharmacy department at Velindre Cancer Centre, will operationally manage the service.

documents

Documents are linked, not mirrored. They are served by the publishing authority and may require registration.

notice history

2 notices published against this procurement.

PublishedTypeRegimeNotice
18 Dec 2023 Contract notice (F02) Earlier regulations 037060-2023
29 Apr 2024 Contract award notice (F03) Earlier regulations 013708-2024

more from NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust)

all contracts from this buyer →

similar contracts awarded

Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.

source

Published on Sell2Wales. Contact details for named individuals are not reproduced on this site.